openPR Logo
Press release

Peanut Allergy Therapeutics Pipeline Review 2018 - Clinical Trials, Patents, Designations and Developments

09-11-2018 03:19 PM CET | Health & Medicine

Press release from: P&S Intelligence - Pharmaceuticals

Peanut Allergy Therapeutics Pipeline Review 2018 - Clinical

Peanut allergy is one of the most common type of allergies caused by a legume, known as peanut. Peanut is an annual herbaceous plant that belongs to the family of legumes. Other examples of legumes that can cause the disease include lentils, peas, and soybeans. Peanut allergy can be unpredictable and life-threatening and can bring the body into shock (anaphylaxis). The study analyzed that peanut allergy therapeutics pipeline comprises approximately 19 drug candidates in different stages of development.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/peanut-allergy-therapeutics-pipeline-analysis/report-sample

According to the research findings, a majority of the drug candidates for the treatment of peanut allergy are being developed to be administered by the oral route which is convenient to take, and has been considered as non-invasive, and is often a safer route that requires no special training to be given to the patients.

It has been observed that most of the companies are developing drug candidates by using advanced technologies and the drug candidates have showed positive efficacy in the clinical as well as Pre-Clinical stage of development. For instance, BioLingus Inc. is utilizing its technology, BioLingus technology, which is a micro-encapsulation process, that delivers macro molecules such as peptides and proteins and is particularly effective for sublingual immunotherapy. With this technology, it has been observed in the Pre-Clinical models that sublingual IL-2 is found efficacious in 500th times lower amount than the investigational sublingual IL-2 therapy for the treatment of peanut allergy.

Browse report at: https://www.psmarketresearch.com/market-analysis/peanut-allergy-therapeutics-pipeline-analysis

Some of the key players involved in the development of peanut allergy therapeutics include Aimmune Therapeutics Inc., DBV Technologies S.A., and AnaptysBio Inc.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peanut Allergy Therapeutics Pipeline Review 2018 - Clinical Trials, Patents, Designations and Developments here

News-ID: 1233640 • Views:

More Releases from P&S Intelligence - Pharmaceuticals

Cyclin-Dependent Kinase Inhibitors Therapeutics Key Players Analysis - Merck, Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim
Cyclin-Dependent Kinase Inhibitors Therapeutics Key Players Analysis - Merck, El …
The study analyzed that the CDK inhibitors therapeutics pipeline comprises approximately 24 drug candidates in different stages of development. CDKs are the catalytic subunits of serine or threonine protein kinases that regulate the checkpoints in the cell cycle to control the proliferative capacity of cancerous cells. These proteins form cyclin-CDK complex which gets activated after phosphorylation, leading to cell proliferation. Download report sample at: http://bit.ly/2eqiPu5 **Various collaborations for CDK inhibitors drug development Eli Lilly
Systemic Lupus Erythematosus Pipeline Analysis - Anthera Pharmaceuticals, Inc., Genentech, Inc., Merck KGaA
Systemic Lupus Erythematosus Pipeline Analysis - Anthera Pharmaceuticals, Inc., …
The study analyzed that the systemic lupus erythematosus pipeline comprises of 57 drug candidates in different stages of development. Explore report sample at: https://www.psmarketresearch.com/market-analysis/systemic-lupus-erythematosus-pipeline-analysis/report-sample Systemic lupus erythematosus is a type of lupus in which the immune system damages its own tissues. The disease affects many parts of the body including skin, joints, lungs, brain, blood vessels and kidneys. The systemic lupus erythematosus is caused by impaired immune system due to which the
Herpes Simplex Virus Infections Therapeutic - Pipeline Analysis, Clinical Trials and Developments
Herpes Simplex Virus Infections Therapeutic - Pipeline Analysis, Clinical Trials …
The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development. As per the findings of the research, most of the drug candidates are being developed to be administered by oral route. Explore report sample at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis/report-sample Many technologies are being developed that offer promising innovative treatments which can control the progression of Herpes simplex virus infections. The technologies include, but not limited to,
Japanese Encephalitis Therapeutics - Pipeline Analysis, Clinical Trials, Patent and Collaborations
Japanese Encephalitis Therapeutics - Pipeline Analysis, Clinical Trials, Patent …
Japanese encephalitis is a viral infection that spreads by mosquito bites. The study analyzed that the Japanese encephalitis therapeutics pipeline comprises approximately 12 drug candidates in different stages of development. Explore report sample at: https://www.psmarketresearch.com/market-analysis/japanese-encephalitis-therapeutics-pipeline/report-sample The companies developing drugs for the treatment of Japanese encephalitis are laying more emphasis on the drug candidates to be developed as vaccines, due to the promising results shown by these candidates the in the clinical development.

All 5 Releases


More Releases for Peanut

Peanut Butter Market 2020-2027 Advance Study Focusing On Major Product Types- S …
Peanut Butter Market Overview 2020-2027: Peanut butter market is anticipated to dominate the market with a market value of USD 4.20 billion in 2019 and is expected to grow with a growth rate of 6.10% in the forecast period of 2020 to 2027.  The latest Market report by a Data Bridge Market Research with the title [Global Peanut Butter Market – Industry Trends and Forecast to 2027].  Get a PDF Sample copy (including COVID-19 impact analysis and up-to 30% discount ) @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-peanut-butter-market  In
Peanut Butter Manufacturing Unit
Peanut butter is a high calorie, high protein product manufactured by grinding peanuts. It is a good alternative for dairy butter and widely used as a bread spread. Peanut butter is popular amongst Americans, and it is a part of their daily breakfast. The demand for peanut butter is susceptible to consumer spending. As disposable income increases, the willingness of the people to purchase the peanut butter also increases. On
Peanut Sauce Market 2019 | Worldwide Forecast 2025 | Major Players – Jif, PBfi …
Peanut Sauce Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/85716 UpMarketResearch offers a latest published report on “Global Peanut Sauce Market Analysis and Forecast 2019 - 2025” delivering key insights and providing a competitive advantage
Drinkable Peanut Powder Market | Top Key Players are Golden Peanut and Tree Nuts …
Peanuts are a high-protein, nutritious food that are ready-to-eat with little preparation or can be eaten raw. Peanut can be processed by roasting and ground into various food products. Peanut shakes and smoothies segments are gaining significant traction in the global drinkable peanut powder market. Rising demand for the healthy beverages such as drinkable peanut powder products driving the market. In addition, food manufacturers are developing peanut powder which is based
Hormel Foods, J.M. Smucker Company, Saratoga Peanut Butter Company, Peanut Butte …
The market for Peanut Paste is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Peanut Paste Market Insights, Forecast to 2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore, an
Peanut Butter Market Report 2018: Segmentation by Product (Regular Peanut Butter …
Global Peanut Butter market research report provides company profile for Hormel Foods Corporation, Boulder Brands, Kraft Canada, Algood Food Company, Procter & Gamble, Unilever, The J.M. Smucker Company and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018